864 related articles for article (PubMed ID: 16946177)
1. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
McGrath PJ; Stewart JW; Fava M; Trivedi MH; Wisniewski SR; Nierenberg AA; Thase ME; Davis L; Biggs MM; Shores-Wilson K; Luther JF; Niederehe G; Warden D; Rush AJ
Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
[TBL] [Abstract][Full Text] [Related]
2. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
[TBL] [Abstract][Full Text] [Related]
3. Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.
Benkert O; Szegedi A; Philipp M; Kohnen R; Heinrich C; Heukels A; van der Vegte-Senden M; Baker RA; Simmons JH; Schutte AJ
J Clin Psychopharmacol; 2006 Feb; 26(1):75-8. PubMed ID: 16415711
[TBL] [Abstract][Full Text] [Related]
4. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
5. Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.
Guelfi JD; Ansseau M; Timmerman L; Kørsgaard S;
J Clin Psychopharmacol; 2001 Aug; 21(4):425-31. PubMed ID: 11476127
[TBL] [Abstract][Full Text] [Related]
6. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
Blier P; Ward HE; Tremblay P; Laberge L; Hébert C; Bergeron R
Am J Psychiatry; 2010 Mar; 167(3):281-8. PubMed ID: 20008946
[TBL] [Abstract][Full Text] [Related]
7. A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.
Fava M; Rush AJ; Wisniewski SR; Nierenberg AA; Alpert JE; McGrath PJ; Thase ME; Warden D; Biggs M; Luther JF; Niederehe G; Ritz L; Trivedi MH
Am J Psychiatry; 2006 Jul; 163(7):1161-72. PubMed ID: 16816220
[TBL] [Abstract][Full Text] [Related]
8. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
[TBL] [Abstract][Full Text] [Related]
9. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
[TBL] [Abstract][Full Text] [Related]
10. [Combining venlafaxine and mirtazapine for the treatment of major depression with dysthymia--"double depression"].
Ladeira RB; Cunha FT; Salgado JV; Teixeira AL; Nicolato R
Braz J Psychiatry; 2008 Sep; 30(3):299-300. PubMed ID: 18833439
[No Abstract] [Full Text] [Related]
11. Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.
Hummel J; Westphal S; Weber-Hamann B; Gilles M; Lederbogen F; Angermeier T; Luley C; Deuschle M; Kopf D
J Clin Psychiatry; 2011 Jul; 72(7):885-91. PubMed ID: 21294998
[TBL] [Abstract][Full Text] [Related]
12. Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial.
Kang EH; Lee IS; Chung SK; Lee SY; Kim EJ; Hong JP; Oh KS; Woo JM; Kim S; Park JE; Yu BH
Psychiatry Res; 2009 Sep; 169(2):118-23. PubMed ID: 19695711
[TBL] [Abstract][Full Text] [Related]
13. Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.
Sung SC; Wisniewski SR; Balasubramani GK; Zisook S; Kurian B; Warden D; Trivedi MH; Rush AJ;
Psychol Med; 2013 May; 43(5):945-60. PubMed ID: 23228340
[TBL] [Abstract][Full Text] [Related]
14. STAR*D level IV methodology.
Wingo AP; Ghaemi SN
Am J Psychiatry; 2007 Apr; 164(4):681; author reply 681. PubMed ID: 17403987
[No Abstract] [Full Text] [Related]
15. Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.
Hannan N; Hamzah Z; Akinpeloye HO; Meagher D
J Psychopharmacol; 2007 Mar; 21(2):161-4. PubMed ID: 17329295
[TBL] [Abstract][Full Text] [Related]
16. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
Amsterdam JD; Wang CH; Shwarz M; Shults J
J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
[TBL] [Abstract][Full Text] [Related]
17. A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report.
Nierenberg AA; Fava M; Trivedi MH; Wisniewski SR; Thase ME; McGrath PJ; Alpert JE; Warden D; Luther JF; Niederehe G; Lebowitz B; Shores-Wilson K; Rush AJ
Am J Psychiatry; 2006 Sep; 163(9):1519-30; quiz 1665. PubMed ID: 16946176
[TBL] [Abstract][Full Text] [Related]
18. Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report.
Sung SC; Wisniewski SR; Luther JF; Trivedi MH; Rush AJ;
J Affect Disord; 2015 Mar; 174():157-64. PubMed ID: 25497473
[TBL] [Abstract][Full Text] [Related]
19. Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response.
Perugi G; Frare F; Toni C; Ruffolo G; Torti C
Neuropsychobiology; 2002; 46(3):145-9. PubMed ID: 12422062
[TBL] [Abstract][Full Text] [Related]
20. Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification.
Liappas J; Paparrigopoulos T; Tzavellas E; Rabavilas A
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):55-60. PubMed ID: 15610945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]